GlobeNewswire·Nov 11, 2026, 5:00 PM ET

MariMed Reports Third Quarter 2026 Earnings

MariMed Inc. reported third-quarter 2026 consolidated revenue of $44.2 million, a 5.5% sequential increase & an 8.5% year-over-year increase, marking the highest quarterly revenue in company history.
Total revenue for the nine months ended September 30, 2026, reached $125.6 million, up 6.3% from $118.2 million in the prior-year period.
GAAP net loss for the quarter was $3.5 million, widening from $2.9 million in the same period last year; non-GAAP net loss was $2.3 million compared to $1.5 million previously.
Non-GAAP Adjusted EBITDA for the quarter was $4.7 million, an 18% sequential increase, with a non-GAAP Adjusted EBITDA margin of 11%.
Wholesale revenue grew 5.2% sequentially & 8.1% year over year, while retail revenue increased 5.4% sequentially & 8.4% year over year.
The company's branded products portfolio gained 150 basis points of market share across core markets, with Betty's Eddies remaining the top-selling edible brand in Massachusetts, Maryland, Illinois, & Delaware.
MariMed's branded products were sold into 721 stores during the quarter, representing a 7% sequential increase & a 13% year-over-year increase.
Transactions across the Thrive retail network grew 2% sequentially & 7% year over year, while average order value increased 3% sequentially & 1% year over year.
The Thrive Perks Loyalty Program membership increased 31% since the beginning of the year.
Cash & cash equivalents stood at $10.4 million at quarter-end, an increase of $1.9 million from the prior quarter, representing the strongest cash position in over two years.
MariMed announced a conference call for November 12, 2026, at 8:00 a.m. Eastern time to discuss these financial results.
The company continues to execute its "Expand the Brand" strategy, focusing on operating efficiencies, capital allocation, & potential federal cannabis reform catalysts.

Company: MariMed Inc.
Keywords: Other OTC:MRMD, MariMed Inc., cannabis, earnings, marimed